Simultaneous 18F-FDG PET/MRI predicting favourable surgical outcome in refractory epilepsy patients
Neuroradiology · 2025
DOI: 10.1007/s00234-024-03446-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroradiology, 2025. Verfasst von Kun Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Drug Resistant Epilepsy, Positron-Emission Tomography, Multimodal Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. imaginglu@hotmail.com.
- Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China. imaginglu@hotmail.com.
Förderung
- The National Key Research and Development Program of China
Zitieren
APA
Guo, K., Hu, J., Cui, B., Wang, Z., Hou, Y., Yang, H., & Lu, J. (2025). Simultaneous 18F-FDG PET/MRI predicting favourable surgical outcome in refractory epilepsy patients. Neuroradiology. https://doi.org/10.1007/s00234-024-03446-4
Vancouver
Guo K, Hu J, Cui B, Wang Z, Hou Y, Yang H, et al. Simultaneous 18F-FDG PET/MRI predicting favourable surgical outcome in refractory epilepsy patients. Neuroradiology. 2025. doi:10.1007/s00234-024-03446-4
BibTeX
@article{Guo2025,
author = {Guo, Kun and Hu, Jie and Cui, Bixiao and Wang, Zhenming and Hou, Yaqin and Yang, Hongwei and Lu, Jie},
title = {Simultaneous 18F-FDG PET/MRI predicting favourable surgical outcome in refractory epilepsy patients},
journal = {Neuroradiology},
year = {2025},
doi = {10.1007/s00234-024-03446-4}
}
EUVIMED